Gaithersburg, MD-based Novavax Inc. recently announced adjusted financial guidance for 2022 to account for several evolving market dynamics. For the second quarter of 2022, total company revenue of $186 million included $78 million of product sales/royalties... READ →
Precision Vaccinations/ August 10th, 2022
Eliminating fake vaccine news with pharmacist, nurse, and physician review.
Aug 10 • 5:17 am CDT
Aug 9 • 7:50 am CDT
New York City-based SIGA Technologies, Inc. today announced the exercise of procurement options under its contract with the U.S. Department of Health and Human Services (HHS) for the delivery of intravenous (IV) formulation of TPOXX® treatment... READ →
Aug 8 • 4:08 pm CDT
France-based Valneva SE and Pfizer Inc. today announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR), to investigate the efficacy, safety, and immunogenicity of their investigational Lyme disease vaccine... READ →
Aug 8 • 3:35 pm CDT
A recent non-peer-reviewed study conducted in Paris, France, describes the outcomes of high-risk contacts receiving the third-generation IMVANEX® (Jynneos) vaccine as an early postexposure ring vaccination (EPRV) and potential monkeypox virus (MPXV) breakthrough infections after the... READ →
Aug 6 • 4:11 am CDT
The West Virginia Department of Health and Human Resources confirmed reports people had developed influenza-like illness after working closely with swine (pigs) at the Jackson County Fair. In addition, laboratory Services returned presumptive positive influenza A(H3N2)... READ →
For more articles, try our search.